Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study

Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lucia Caminiti, Francesca Galletta, Simone Foti Randazzese, Paolo Barraco, Stefano Passanisi, Antonella Gambadauro, Giuseppe Crisafulli, Mariella Valenzise, Sara Manti
Formato: Artigo
Idioma:Inglês
Publicado em: 2024
Acesso em linha:https://doi.org/10.3390/children11020170
https://www.mdpi.com/2227-9067/11/2/170/pdf?version=1706432217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!